Stocks and Finance

Merck

Tuesday, February 07, 2012 Merck

Click on the link to see more recent Merck news

Merck 2/7/2012

14:25 : Summary Box: Merck reports anti-clot drug data - STRIKE TWO: A second study shows Merck's experimental anti-clotting drug vorapaxar increased risk of dangerous internal bleeding, including inside the skull. The study, called TRA-2P, did show vorapaxar lowered risk of heart attack, stroke and death....
Source : usnews-com
13:20 : Merck anti-clot compound again shows bleeding risk - TRENTON, N.J. (AP) -- An experimental anti-clotting drug that Merck & Co. is developing was found to increase risk of dangerous internal bleeding in a second study, meaning it's unlikely to achieve the blockbuster status ...
Source : usnews-com
acciones Merck -
Logo Merck

Merck by date


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts